Research questions that the OHDSI community can potentially answer to suport the COVID-19 response

Referencing these articles: https://www.bmj.com/content/368/bmj.m810/rr-2 and https://pubmed.ncbi.nlm.nih.gov/32129518-angiotensin-receptor-blockers-as-tentative-sars-cov-2-therapeutics/ Questions that would be interesting to ask of the OHDSI network

  1. Is ACE inhibitor usage a risk factor for severe disease/death?
  2. Is AT1 blocker (e.g. losartan) a risk or protective factor for severe disease/death?
4 Likes